Patient Derived Xenograft Model Market Will Grow at Highest Pace Owing to Rising Presence of CROs and Pharma Giants

The patient derived xenograft model market comprises animal models that help derive critical preclinical data from human cancer samples for drug development and discovery. These models provide human cancer cell lines and organoids that mirror patient's cancer biology and help evaluate new drugs. The global models provide an alternative to conventional cell lines and enable personalized testing of anticancer therapies with utmost precision.